Cannabis Movers & Shakers: Mind Medicine, 22nd Century Group, Grown Rogue International

Mind Medicine Names New CEO

Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) has hired Schond L. Greenway to oversee its finance department.

Greenway comes to MindMed with over two decades of experience in investment banking, finance and corporate advisory, and investment analysis in the life sciences sector.

Previously he served as CFO of Avalo Therapeutics and vice president of investor relations at Mesoblast, while he also served in a similar role at Halozyme Therapeutics, Inc. (NASDAQ: HALO).

“Second is joining MindMed at an exciting point in our growth, with numerous near-term milestones ahead across our pipeline,” Robert Barrow, CEO and director of MindMed said. “I look forward to working closely with him to advance our mission of becoming a global leader in the development of innovative therapies for brain health disorders.”

John J. Miller …

Full story available on Benzinga.com

More Cannabis Movers & Shakers: Mind Medicine, 22nd Century Group, Grown Rogue International